Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Ball

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Homoeopathic Physician|May 3, 2023
Is Camphor the Genus Epidemicus of the Present Cholera Invasion?G R Ball
Ear, Nose, & Throat Journal|April 1, 1997
Scanning laser Doppler vibrometry of the middle ear ossiclesG R Ball, A Huber, R L Goode
Ear, Nose, & Throat Journal|May 1, 1997
Implantable hearing device performance measured by laser Doppler interferometryR Z Gan, M W Wood, G R Ball, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1981
A high velocity impact device for obtaining multiple, contiguous, myocardial biopsiesD J Hearse, D M Yellon, D A Chappell, et al.
Breast Cancer Research and Treatment|December 5, 2012
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancerB G Baker, G R Ball, E A Rakha, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2007
Reading the prognosis of the individual with breast cancerR W Blamey, S E Pinder, G R Ball, et al.
Breast Cancer Research and Treatment|July 11, 2009
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancerH Zhang, E A Rakha, G R Ball, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
British Journal of Cancer|September 7, 2013
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkersA R Green, D G Powe, E A Rakha, et al.
Breast Cancer Research and Treatment|April 27, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Homoeopathic Physician|May 3, 2023
Is Camphor the Genus Epidemicus of the Present Cholera Invasion?G R Ball
Ear, Nose, & Throat Journal|April 1, 1997
Scanning laser Doppler vibrometry of the middle ear ossiclesG R Ball, A Huber, R L Goode
Ear, Nose, & Throat Journal|May 1, 1997
Implantable hearing device performance measured by laser Doppler interferometryR Z Gan, M W Wood, G R Ball, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1981
A high velocity impact device for obtaining multiple, contiguous, myocardial biopsiesD J Hearse, D M Yellon, D A Chappell, et al.
Breast Cancer Research and Treatment|December 5, 2012
Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancerB G Baker, G R Ball, E A Rakha, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2007
Reading the prognosis of the individual with breast cancerR W Blamey, S E Pinder, G R Ball, et al.
Breast Cancer Research and Treatment|July 11, 2009
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancerH Zhang, E A Rakha, G R Ball, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
British Journal of Cancer|September 7, 2013
Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkersA R Green, D G Powe, E A Rakha, et al.
Breast Cancer Research and Treatment|April 27, 2016
Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancerAndrew R Green, D Soria, D G Powe, et al.
Pageof 2